Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Q Timour

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Cardiovascular Drugs and Therapy|December 1, 1994
Time course of electrical fibrillation threshold during brief periods of myocardial ischemia and the genesis of fibrillation: role of calciumQ Timour, J F Aupetit, G Chevrel, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1988
Frequency- and time-dependent depression of ventricular distal conduction by two novel antiarrhythmic drugs, cibenzoline and flecainideJ Lang, Q Timour, J F Aupetit, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1993
Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazemJ F Aupetit, Q Timour, G Chevrel, et al.
Bulletin De L'Academie Nationale De Medecine|July 2, 1998
[Cardiac accidents of locoregional anesthesia: experimental study of risk factors with bupivacaine]Q Timour, P Gaillard, B Bui-Xuan, et al.
Journal De Pharmacologie|July 1, 1983
Influence of the restoration of vagal tone by intracisternal injection of dextromoramide on the cardiac effects of the antiarrhythmic drugsL Bertrix, B Bui-Xuan, J Lang, et al.
Cardiovascular Research|July 11, 1998
Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia durationJ F Aupetit, D Frassati, B Bui-Xuan, et al.
Regional Anesthesia|July 1, 1990
Possible role of drug interactions in bupivacaine-induced problems related to intraventricular conduction disordersQ Timour, M Freysz, P Couzon, et al.
Archives Internationales De Physiologie Et De Biochimie|May 1, 1981
Modifications by ischemia of carbohydrate and lipid metabolism of the dog heart in situ from circulating and endogenous substratesJ L Andrieu, S Al Makdessi, Q Timour Chah, et al.
Acta Anaesthesiologica Scandinavica|April 1, 1997
Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusionJ F Aupetit, M Freysz, G Faucon, et al.
Canadian Journal of Physiology and Pharmacology|March 18, 2000
Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarizationJ F Aupetit, B Bui-Xuan, I Kioueh, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Cardiovascular Drugs and Therapy|December 1, 1994
Time course of electrical fibrillation threshold during brief periods of myocardial ischemia and the genesis of fibrillation: role of calciumQ Timour, J F Aupetit, G Chevrel, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1988
Frequency- and time-dependent depression of ventricular distal conduction by two novel antiarrhythmic drugs, cibenzoline and flecainideJ Lang, Q Timour, J F Aupetit, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1993
Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazemJ F Aupetit, Q Timour, G Chevrel, et al.
Bulletin De L'Academie Nationale De Medecine|July 2, 1998
[Cardiac accidents of locoregional anesthesia: experimental study of risk factors with bupivacaine]Q Timour, P Gaillard, B Bui-Xuan, et al.
Journal De Pharmacologie|July 1, 1983
Influence of the restoration of vagal tone by intracisternal injection of dextromoramide on the cardiac effects of the antiarrhythmic drugsL Bertrix, B Bui-Xuan, J Lang, et al.
Cardiovascular Research|July 11, 1998
Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia durationJ F Aupetit, D Frassati, B Bui-Xuan, et al.
Regional Anesthesia|July 1, 1990
Possible role of drug interactions in bupivacaine-induced problems related to intraventricular conduction disordersQ Timour, M Freysz, P Couzon, et al.
Archives Internationales De Physiologie Et De Biochimie|May 1, 1981
Modifications by ischemia of carbohydrate and lipid metabolism of the dog heart in situ from circulating and endogenous substratesJ L Andrieu, S Al Makdessi, Q Timour Chah, et al.
Acta Anaesthesiologica Scandinavica|April 1, 1997
Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusionJ F Aupetit, M Freysz, G Faucon, et al.
Canadian Journal of Physiology and Pharmacology|March 18, 2000
Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarizationJ F Aupetit, B Bui-Xuan, I Kioueh, et al.
Pageof 9